TAMMY HAWKINS: Open Payments
NPI 1215212089 · JONESBORO, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$971 in 42 payments from 11 companies in 2025. Trend: 2023 $2,161 · 2024 $2,607 · 2025 $971
Food & beverage: $971
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 11 | $352 |
| Janssen Pharmaceuticals, Inc | 9 | $227 |
| ABBVIE INC. | 13 | $207 |
| E.R. Squibb & Sons, L.L.C. | 2 | $43 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $29 |
| Alkermes, Inc. | 1 | $23 |
| Tris Pharma Inc | 1 | $22 |
| Lundbeck LLC | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
| Neurocrine BioSciences, Inc. | 1 | $17 |
Products named: Auvelity, SPRAVATO, VRAYLAR, COBENFY, CAPLYTA, ARISTADA, Dyanavel XR, REXULTI.
Industry payments across AR — which companies pay providers there.
